Kronos Bio, Inc.
Kronos Bio, Inc.

Kronos Bio, Inc.

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Kronos Bio, Inc. Jobs and Salary Info

Find High Paying Jobs, Compensation Information and Expert Network Connections at Kronos Bio, Inc.

Kronos Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer therapeutics designed to transform patient outcomes. The company's lead product candidate, entospletinib, is a selective inhibitor of spleen tyrosine kinase (SYK) that is being evaluated in multiple clinical trials for the treatment of hematological malignancies and solid tumors. Kronos Bio is also advancing a pipeline of small molecule inhibitors targeting other key drivers of cancer, including cyclin-dependent kinases (CDKs) and MYC. The company was founded in 2018 and is headquartered in Alameda, California.


Market Cap$85.8 million
pie chartAnnual Report
stats icon
Total value of jobs:
stats icon
Average Pay:
stats icon
Total Experts:

Top Experts at Kronos Bio, Inc.